HK Hot Stock Analysis: Great Health International (02211.HK)

Great Health International (02211.HK) is a leading pharmaceutical retailer and distributor in Northeast China. As of the latest data, it operates 953 retail pharmacies in Northeast China and 4 in Hong Kong, with approximately 6,500 distribution customers [2]. According to data from Oriental Fortune App’s HK Stock Surge List (Tushare dc_hot), the stock entered the hot list on December 25, 2025 (UTC+8, Christmas) [1], but the Hong Kong Stock Exchange (HKEX) was closed that day, so actual trading activity may be either advanced or delayed data. The company’s latest publicly disclosed FY2025 (ending June) results show that revenue decreased by 34.7% year-on-year to RMB 712 million, and net profit turned from profit to loss at -RMB 26.01 million [2]. From a technical perspective, the stock formed a ‘death cross’ technical pattern (10-day moving average fell below the 20-day moving average) on December 17 [2]; historical data on December 18 shows that the share price closed at HKD 1.760 per share, down 6.88%, with a trading volume of 15,000 shares and a turnover rate of 0.01% [3].

1. Timing Contradiction and Signal Validity
   : The hot list signal appeared on a HKEX closed day, so its timeliness and accuracy are questionable and need to be verified with subsequent actual trading data.
2. Fundamentals vs. Hot List Performance Divergence
   : The company’s recent performance has declined significantly, and it has not released any clear positive announcements or events that could drive a stock price surge. The hot list performance lacks fundamental support.
3. Technical and Liquidity Risks
   : The “death cross” technical signal is usually regarded as a bearish signal. Combined with low historical trading volume (insufficient trading activity), the risk of stock price volatility is high.

• Key Risks
  : Deteriorating fundamentals (both revenue and net profit declined) [2], bearish technical pattern [2], lack of clear upward catalysts, liquidity risk (low trading volume) [3].
• Potential Opportunities
  : If the company releases new announcements such as business transformation, mergers and acquisitions, or favorable policies, it may change the current trend, but there is no relevant information at present [0].

Although Great Health International (02211.HK) entered the Oriental Fortune App hot list on a HKEX closed day, it currently lacks clear catalysts for a stock price rise, and both fundamentals and technicals show unfavorable signals. Investors need to pay attention to the company’s subsequent announcements and actual trading data, and carefully evaluate its investment value [0].